Lorven Biologics Germany    
Logo
Home About us Mission Service Therapeutics Food and Cosmetics
Bild about us

 

About us

SCIENTIFIC ADVISORY BOARD

 
 

Dr. Bhuwnesh Agrawal, MD, MBA, Certified Specialist for Pharmacology and Toxicology, Clinical Pharmacology and Internal Medicine

C-level executive with broad multicultural experience in the health care industry, including Life Sciences, Diagnostics, Medical Devices and Pharmaceuticals in B2B and B2C. Excellent track record in executive management, strategy, business development, marketing and sales. Acknowledged for groundbreaking innovations, creative ideas, effective process and turnaround management and strong inspirational and people-oriented leadership skills resulting in consistent sustainable growth. His key interest is to work as a top leader in an international organization to maximize its potential through clear direction and operational excellence.

PROFESSIONAL EXPERIENCE (2004 - today)

President and CEO, Sysmex Inostics GmbH Hamburg, Germany
- Leading the liquid biopsy startup company by creating and implementing a turnaround strategy

Head of Region Asia Pacific Africa (>400-600 FTE; 90-180 Mio €) Eppendorf AG, Hamburg, Germany
- Increased the growth rate from low single digits to double digit within 1 year by changing strategy and market approach.
- Achieved a turnaround for Latin America before transferring it effective 2019

Co-Founder & Chief Medical Officer, Member of Executive Committee Vela Holding Pte Ltd., Singapore
- Serving in multiple functions in this start-up established in 2011. Involved in all medical decisions of company as well as design of first infectious and oncology NGS tests worldwide with regulatory approval.
- Initiated sales in APAC and with Pharma accounts.

Chairman and Managing Director South Asia (500 FTE, 100 Mio CHF) Roche Diagnostics India Pvt. Ltd., Mumbai, India
- Increased growth and attained market leadership position in the Indian diagnostic market within 2 years (growing at 2-3x market growth over the period); increased profitability though shift in business model, process improvements and reduction in attrition from 40% to 12%. Turned around business in Bangladesh and Sri Lanka from a growth rate of -10%/ year to approx. 30%.
- Member of APAC Leadership Team and global Applied Science business team. In charge of Applied Science Business in APAC, doubling sales in the region in 3 years.

Head of Roche Applied Science Business Unit Germany (23 FTE, 80 Mio €) Roche Diagnostics GmbH, Mannheim, Germany
- Achieved turnaround for Roche Applied Science Business Unit (-5% to +8%) within one year with same team. Created the most efficient Business Unit (sales/FTE, M&D expenses) globally for Applied Science and within the German organization.
- European Team Leader and member of global Applied Science Operating Committee.

 
   
  © Lorven Biologics Germany 2023   Contact   Imprint